查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2046250

體外膜氧合（ECMO）系統市場－全球產業規模、佔有率、趨勢、機會、預測：依方法、應用、最終用戶、地區和競爭格局分類，2021-2031年

Extra Corporeal Membrane Oxygenation System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality, By Application, By End-User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球體外膜氧合（ECMO）系統市場預計將從 2025 年的 5.752 億美元成長到 2031 年的 8.0949 億美元，複合年成長率為 5.86%。

體外膜氧合（ECMO）系統是一種先進的醫療設備，它透過向體外血液供氧，為嚴重心臟衰竭衰竭患者的心臟和呼吸功能提供長期支持。市場的成長主要受以下因素驅動：慢性心肺疾病盛行率的上升、全球易患嚴重器官衰竭的老年人口的快速成長，以及這些系統在成人加護病房（ICU）的臨床應用不斷擴大。例如，體外維生系統（ELSO）在其2025年4月的註冊報告中指出，截至2024年，全球已完成245,291總合體外維生手術，顯示該技術已被廣泛應用。

市場概覽
預測期： 2027-2031
市場規模：2025年 5.752億美元
市場規模：2031年 8.0949億美元
複合年成長率：2026-2031年 5.86%
成長最快的細分市場 醫院和診所
最大的市場 北美洲

儘管ECMO市場發展迅速，但仍面臨許多挑戰，包括部署ECMO設備的高昂成本以及治療本身的複雜性。管理這些先進設備並降低出血和感染疾病等嚴重風險需要專業的跨學科團隊，這限制了其在小規模醫療機構的應用。因此，高昂的成本和訓練有素的專業人員嚴重短缺是該技術在不同醫療機構廣泛應用的主要障礙。

市場促進因素

設備便攜性和小型化的技術進步是全球體外膜氧合（ECMO）系統市場的主要驅動力，使得ECMO能夠快速部署到傳統醫院以外的場所。緊湊輕巧系統的開發使得早期療育，轉運過程也更加安全，從而將生命維持能力擴展到救護車和小規模醫療機構。 Inspira Technologies公司的INSPIRA ART100系統便是此一趨勢的例證。該系統是一種微創血氧合技術，已於2024年5月獲得FDA 510(k)批准。此外，大量研究投入，例如約翰霍普金斯醫學中心於2024年12月津貼超過1,800萬美元用於開發攜帶式、可快速部署的ECMO設備，也進一步推動了這些能力的提升。

同時，全球嚴重心肺疾病發生率的上升是推動機械循環支援設備需求成長的重要因素。隨著慢性心臟衰竭和呼吸困難的日益普遍，為穩定患者病情以便康復或進行心臟移植，對過渡性治療方法的需求也隨之增加。美國心臟協會 (AHA) 2024 年 1 月發布的心臟病和中風統計報告強調了這一負擔，指出美國每年死於心血管疾病的人數將超過 80 萬人。這表明臨床上對體外膜氧合 (ECMO) 等先進干預措施的需求非常高。不斷擴大的患者群體促使醫療專業人員將體外循環支持納入標準重症監護方案，以應對這些致命疾病。

市場挑戰

全球體外膜氧合（ECMO）系統市場的成長受到高昂成本和熟練專業人員嚴重短缺的極大限制。體外生命支持療法複雜，不僅需要昂貴的設備，還需要一支能夠全天候運作的專業多學科團隊。這項要求對小規模的醫療機構和發展中地區構成了重大障礙，市場滲透主要局限於資源充足的大規模大學醫院。

因此，由於無法普遍實施這些系統，限制了潛在部署的設備數量和實際操作次數。體外膜氧合（ECMO）治療的複雜性要求進行精細的管理以最大程度地降低風險，這反過來又加劇了對高技能專業人員本已短缺的需求。根據2025年4月發布的《體外生命支持系統國際註冊報告》（ELSO），這些重症病患的整體出院或轉院存活率為64%，這顯示需要高水準的專業技術。這凸顯了合格人員的短缺直接阻礙了ECMO技術的廣泛應用。

市場趨勢

體外心肺復甦術（ECPR）的快速普及正在改變急診醫療實踐，它能為難治性心臟麻痹提供即時循環支持。由於ECPR能夠延長標準復甦方法無效時的關鍵干預期，因此在先進的醫療機構中，ECPR的應用日益廣泛。隨著醫療機構對插管技術的規範化，這項高難度操作的臨床成功率也顯著提高。例如，發表於2025年1月《急診醫學年鑑》（Annals of Emergency Medicine）的一項研究報告顯示，37%的ECPR患者在研究結束時獲得了良好的神經系統預後，這印證了ECPR的積極發展趨勢。

同時，採用清醒和可活動體外膜氧合（ECMO）方案的趨勢日益明顯，改善了等待器官移植患者的照護。這種創新方法最大限度地減少了鎮靜和人工呼吸器的需求，使患者能夠保持身體活動能力，並預防術前肌肉萎縮。透過在體外循環支持期間優先進行康復，醫護人員顯著提高了患者的穩定性，並提高了移植後生存率。 2024年7月出版的《美國人工器官學會雜誌》（ASAIO Journal）重點介紹了這一策略的有效性，其中，等待移植的可活動靜脈-靜脈ECMO患者的90天生存率達到86%，顯著高於不可活動組。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球體外膜氧合（ECMO）系統市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依方法（靜脈-動脈（VA）、靜脈-靜脈（VV）、其他）
    • 依應用領域（呼吸系統應用、心臟應用、體外心肺復甦術（ECPR））
    • 依最終使用者（醫院/診所、門診中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美體外膜氧合（ECMO）系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲體外膜氧合（ECMO）系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區體外膜氧合（ECMO）系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲體外膜氧合（ECMO）系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲體外膜氧合（ECMO）系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布

第13章 全球體外膜氧合（ECMO）系統市場：SWOT分析

第14章：波特五力分析

  • 產業內部競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Alung Technologies Inc.
  • Eurosets
  • Getinge AB
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nipro Medical Corporation
  • Terumo Medical Corporation
  • Abbott Laboratories
  • Fresenius Medical Care Company

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17489

The Global Extra Corporeal Membrane Oxygenation (ECMO) System Market is projected to expand from USD 575.2 Million in 2025 to USD 809.49 Million by 2031, exhibiting a Compound Annual Growth Rate of 5.86%. ECMO systems are advanced medical devices that offer extended cardiac and respiratory assistance by oxygenating blood outside the body for individuals suffering from severe heart or lung failure. This market growth is primarily driven by the increasing incidence of chronic cardiopulmonary conditions, a burgeoning global elderly population prone to critical organ dysfunction, and the expanding clinical deployment of these systems within adult intensive care units. For instance, the Extracorporeal Life Support Organization (ELSO) reported a total of 245,291 extracorporeal life support procedures globally through 2024, as noted in its April 2025 registry report, highlighting widespread utilization.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 575.2 Million
Market Size 2031USD 809.49 Million
CAGR 2026-20315.86%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Despite this growth, the market faces considerable challenges, notably the significant costs associated with acquiring ECMO devices and the complex nature of the therapy itself. Managing this sophisticated equipment and mitigating severe risks, such as bleeding or infection, necessitates a specialized multidisciplinary team, which in turn limits accessibility for smaller healthcare facilities. Therefore, the substantial financial outlay and a critical scarcity of trained professionals pose major impediments to the widespread adoption of this technology across varied healthcare infrastructures.

Market Driver

Technological progress in device portability and miniaturization is a primary catalyst for the Global ECMO System Market, facilitating quick deployment beyond conventional hospital environments. The development of compact, lightweight systems enables earlier patient intervention and safer transportation, extending life support capabilities to ambulances and smaller medical facilities. This trend is exemplified by Inspira Technologies' FDA 510(k) clearance in May 2024 for its INSPIRA ART100 system, a less invasive blood oxygenation technology. Furthermore, significant research investment, such as the over $18 million awarded to Johns Hopkins Medicine in December 2024 for creating a portable, rapid-deployment ECMO device, is further advancing these capabilities.

Simultaneously, the increasing worldwide occurrence of severe cardiopulmonary disorders is a crucial factor sustaining the demand for mechanical circulatory support. As chronic heart failure and respiratory distress become more prevalent, the need for transitional therapies to stabilize patients for recovery or transplantation intensifies. The American Heart Association's January 2024 report on heart disease and stroke statistics underscores this burden, noting over 800,000 annual cardiovascular disease deaths in the U.S., which highlights the profound clinical requirement for advanced interventions like ECMO. This expanding patient demographic motivates healthcare providers to incorporate extracorporeal support into standard critical care protocols for managing highly fatal conditions.

Market Challenge

The Global ECMO System Market's growth is considerably constrained by substantial financial costs and a severe scarcity of skilled professionals. Extracorporeal life support therapy is complex, requiring not only costly equipment but also a specialized, multidisciplinary team of experts available 24/7. This requirement establishes a significant hurdle for smaller healthcare facilities and developing regions, largely restricting market penetration to major, well-resourced academic medical centers.

As a result, the inability to implement these systems universally limits both the potential installed base and the volume of procedures performed. The intricate nature of ECMO therapy mandates diligent management to minimize risks, thereby increasing the demand for highly skilled professionals who are already in short supply. The Extracorporeal Life Support Organization's April 2025 international registry report indicates an overall survival rate of 64% to discharge or transfer for these high-acuity patients, underscoring the high level of proficiency needed. This highlights how the shortage of qualified personnel directly impedes the broader adoption of ECMO technology.

Market Trends

The swift integration of Extracorporeal Cardiopulmonary Resuscitation (ECPR) is transforming emergency medical practices by offering immediate circulatory support for refractory cardiac arrest. This method extends the critical intervention period when standard resuscitation proves ineffective, leading to its growing implementation in advanced medical facilities. As healthcare institutions standardize their cannulation techniques, the clinical success rates for this demanding procedure are showing a notable improvement. For example, an article in the Annals of Emergency Medicine (January 2025) reported that favorable neurological outcomes for ECPR patients rose to 37% by the end of the study, confirming this positive trend.

Concurrently, there is a clear trend towards adopting awake and ambulatory ECMO protocols, which are enhancing care for patients awaiting organ transplants. This innovative approach minimizes the need for sedation and mechanical ventilation, allowing patients to retain physical mobility and prevent muscle wasting before surgery. By prioritizing rehabilitation during extracorporeal support, medical professionals are significantly improving patient stability and viability for post-transplant success. The effectiveness of this strategy is highlighted in the ASAIO Journal (July 2024), where the 90-day waitlist survival rate for ambulatory veno-venous ECMO patients reached 86%, considerably surpassing that of non-ambulatory groups.

Key Market Players

  • Alung Technologies Inc.
  • Eurosets
  • Getinge AB
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nipro Medical Corporation
  • Terumo Medical Corporation
  • Abbott Laboratories
  • Fresenius Medical Care Company

Report Scope

In this report, the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Modality

  • Veno-Arterial (VA)
  • Veno-Venous (VV)
  • Others

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Application

  • Respiratory Applications
  • Cardiac Applications
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By End-User

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market.

Available Customizations:

Global Extra Corporeal Membrane Oxygenation (ECMO) System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Modality (Veno-Arterial (VA), Veno-Venous (VV), Others)
    • 5.2.2. By Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR))
    • 5.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Modality
    • 6.2.2. By Application
    • 6.2.3. By End-User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Modality
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-User
    • 6.3.2. Canada Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Modality
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-User
    • 6.3.3. Mexico Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Modality
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-User

7. Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Modality
    • 7.2.2. By Application
    • 7.2.3. By End-User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Modality
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-User
    • 7.3.2. France Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Modality
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-User
    • 7.3.3. United Kingdom Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Modality
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-User
    • 7.3.4. Italy Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Modality
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-User
    • 7.3.5. Spain Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Modality
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-User

8. Asia Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Modality
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Modality
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-User
    • 8.3.2. India Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Modality
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-User
    • 8.3.3. Japan Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Modality
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-User
    • 8.3.4. South Korea Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Modality
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-User
    • 8.3.5. Australia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Modality
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-User

9. Middle East & Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Modality
    • 9.2.2. By Application
    • 9.2.3. By End-User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Modality
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-User
    • 9.3.2. UAE Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Modality
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-User
    • 9.3.3. South Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Modality
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-User

10. South America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Modality
    • 10.2.2. By Application
    • 10.2.3. By End-User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Modality
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-User
    • 10.3.2. Colombia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Modality
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-User
    • 10.3.3. Argentina Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Modality
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Alung Technologies Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Eurosets
  • 15.3. Getinge AB
  • 15.4. Medtronic PLC
  • 15.5. Microport Scientific Corporation
  • 15.6. Nipro Medical Corporation
  • 15.7. Terumo Medical Corporation
  • 15.8. Abbott Laboratories
  • 15.9. Fresenius Medical Care Company

16. Strategic Recommendations

17. About Us & Disclaimer